610 related articles for article (PubMed ID: 10512690)
1. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
2. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
Janusz MJ; Doherty NS
J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
[TBL] [Abstract][Full Text] [Related]
3. Effect of leukocyte proteinases on tissue factor pathway inhibitor.
Petersen LC; Bjørn SE; Nordfang O
Thromb Haemost; 1992 May; 67(5):537-41. PubMed ID: 1519213
[TBL] [Abstract][Full Text] [Related]
4. Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G.
Speer CP; Pabst MJ; Hedegaard HB; Rest RF; Johnston RB
J Immunol; 1984 Oct; 133(4):2151-6. PubMed ID: 6088632
[TBL] [Abstract][Full Text] [Related]
5. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
[TBL] [Abstract][Full Text] [Related]
6. Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patients.
Lee KO; Oh Y; Giudice LC; Cohen P; Peehl DM; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1367-72. PubMed ID: 7525634
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil elastase potentiates cathepsin G-induced platelet activation.
Selak MA
Thromb Haemost; 1992 Nov; 68(5):570-6. PubMed ID: 1333649
[TBL] [Abstract][Full Text] [Related]
8. Proteolysis of C3 on U937 cell plasma membranes. Purification of cathepsin G.
Maison CM; Villiers CL; Colomb MG
J Immunol; 1991 Aug; 147(3):921-6. PubMed ID: 1861080
[TBL] [Abstract][Full Text] [Related]
9. Protease-modulation of neutrophil superoxide response.
Kusner DJ; King CH
J Immunol; 1989 Sep; 143(5):1696-702. PubMed ID: 2547873
[TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3.
Fielder PJ; Rosenfeld RG; Graves HC; Grandbois K; Maack CA; Sawamura S; Ogawa Y; Sommer A; Cohen P
Growth Regul; 1994 Dec; 4(4):164-72. PubMed ID: 7538844
[TBL] [Abstract][Full Text] [Related]
11. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases.
Kanzaki S; Hilliker S; Baylink DJ; Mohan S
Endocrinology; 1994 Jan; 134(1):383-92. PubMed ID: 7506211
[TBL] [Abstract][Full Text] [Related]
12. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells.
Parker A; Gockerman A; Busby WH; Clemmons DR
Endocrinology; 1995 Jun; 136(6):2470-6. PubMed ID: 7538463
[TBL] [Abstract][Full Text] [Related]
13. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5.
Nam TJ; Busby WH; Clemmons DR
Endocrinology; 1994 Oct; 135(4):1385-91. PubMed ID: 7523096
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells.
Senior RM; Campbell EJ
J Immunol; 1984 May; 132(5):2547-51. PubMed ID: 6562154
[TBL] [Abstract][Full Text] [Related]
15. [Various properties of cathepsin G and elastase from swine peripheral blood neutrophils].
Kraeva LN; Kokriakov VN; Chesnokov IN; Iakovleva MF; Lyzlova SN
Biokhimiia; 1988 Apr; 53(4):655-62. PubMed ID: 3395645
[TBL] [Abstract][Full Text] [Related]
16. Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G.
Owen CA; Campbell MA; Boukedes SS; Campbell EJ
J Immunol; 1995 Dec; 155(12):5803-10. PubMed ID: 7499869
[TBL] [Abstract][Full Text] [Related]
17. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis.
Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM
J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205
[TBL] [Abstract][Full Text] [Related]
19. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
Lalou C; Silve C; Rosato R; Segovia B; Binoux M
Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity.
Bereket A; Lang CH; Blethen SL; Fan J; Frost RA; Wilson TA
J Clin Endocrinol Metab; 1995 Aug; 80(8):2282-8. PubMed ID: 7543110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
